 |
 |
Basically, the company that makes the continuous infusion version in Europe (Britannia) is collaborating with the company that makes the subcutaneous injection version in the states (Vernalis) to develop a continuous sub-cutaneous infusion of apomorphine in North America. This release is dated 11/05 http://www.vernalis.com/ver/nc/latestreleases/releases2005/2005-04-11a/ Collaboration with Britannia to Develop New Formulations of Apomorphine for the Treatment of Parkinson’s Disease 04 November 2005 Vernalis plc (LSE: VER, NASDAQ: VNLS) today announces a collaboration with Britannia Pharmaceuticals Limited (Britannia), to explore the development of new formulations of apomorphine in North America for the treatment of Parkinson’s disease. Britannia has granted Vernalis exclusive rights to: Use Britannia’s technology to develop a continuous sub-cutaneous infusion of apomorphine in North America. This product is currently marketed in Europe by Britannia and can be used in patients with frequent fluctuations or who require multiple injections in a day. Negotiate terms to develop a nasal powder formulation of apomorphine in North America. Britannia is currently conducting Phase II clinical trials with this formulation in Europe. Vernalis also announced today the acquisition of Apokyn® (apomorphine hydrochloride injection) which is indicated for the acute, intermittent treatment of “off” episodes associated with Parkinson’s disease. Simon Sturge, CEO of Vernalis said “This agreement with Britannia complements our acquisition of Apokyn® and further strengthens our Parkinson’s disease franchise.” Lyn Frank <[log in to unmask]> wrote: THANK YOU, LYN ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn __________________________________________________ Do You Yahoo!? Tired of spam? Yahoo! Mail has the best spam protection around ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn http://mail.yahoo.com